Body Composition Among HIV-Seropositive and HIV-Seronegative Adult Patients with Pulmonary Tuberculosis in Uganda

Purpose We determined whether human immunodeficiency virus (HIV) infection affects body cell mass and fat mass wasting among adults with pulmonary tuberculosis (PTB). Methods We screened 967 Ugandan adults for PTB and HIV infection in a cross-sectional study. We compared anthropometric and bioelectr...

Full description

Saved in:
Bibliographic Details
Published inAnnals of epidemiology Vol. 20; no. 3; pp. 210 - 216
Main Authors Mupere, Ezekiel, MBChB, MMED, MS, Zalwango, Sarah, MBChB, Chiunda, Allan, MPH, Okwera, Alphonse, MBChB, Mugerwa, Roy, MBChB, MMED, Whalen, Christopher, MD, MS
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose We determined whether human immunodeficiency virus (HIV) infection affects body cell mass and fat mass wasting among adults with pulmonary tuberculosis (PTB). Methods We screened 967 Ugandan adults for PTB and HIV infection in a cross-sectional study. We compared anthropometric and bioelectric impedance analysis (BIA) body composition parameters among HIV-seropositive and HIV-seronegative men and women with or without PTB by using a non-parametric test. Results We found that poor nutritional status associated with TB differed among men and women. Anthropometric and BIA body composition did not differ between HIV-seropositive and HIV-seronegative patients regardless of gender. Average weight group difference in men consisted of body cell mass and fat mass in equal proportions of 43%. In women, average weight group difference consisted predominantly of fat mass of 73% and body cell mass of 13%. Compared to individuals without TB, patients with TB had lower body mass index, weight, body cell mass, and fat mass regardless of gender and HIV status. Conclusions Gender, but not HIV status, was associated with body composition changes in TB. TB appears to be the dominant factor driving the wasting process among co-infected patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1047-2797
1873-2585
DOI:10.1016/j.annepidem.2009.11.001